Targeted detection and quantitation of histone modifications from 1,000 cells
PLOS ONE
Authors: Abshiru, Nebiyu A.; Sikora, Jacek W.; Camarillo, Jeannie M.; Morris, Juliette A.; Compton, Philip D.; Lee, Tak; Neelamraju, Yaseswini; Haddox, Samuel; Sheridan, Caroline; Carroll, Martin; Cripe, Larry D.; Tallman, Martin S.; Paietta, Elisabeth M.; Melnick, Ari M.; Thomas, Paul M.; Garrett-Bakelman, Francine E.; Kelleher, Neil L.
Abstract
Histone post-translational modifications (PTMs) create a powerful regulatory mechanism for maintaining chromosomal integrity in cells. Histone acetylation and methylation, the most widely studied histone PTMs, act in concert with chromatin-associated proteins to control access to genetic information during transcription. Alterations in cellular histone PTMs have been linked to disease states and have crucial biomarker and therapeutic potential. Traditional bottom-up mass spectrometry of histones requires large numbers of cells, typically one million or more. However, for some cell subtype-specific studies, it is difficult or impossible to obtain such large numbers of cells and quantification of rare histone PTMs is often unachievable. An established targeted LC-MS/MS method was used to quantify the abundance of histone PTMs from cell lines and primary human specimens. Sample preparation was modified by omitting nuclear isolation and reducing the rounds of histone derivatization to improve detection of histone peptides down to 1,000 cells. In the current study, we developed and validated a quantitative LC-MS/MS approach tailored for a targeted histone assay of 75 histone peptides with as few as 10,000 cells. Furthermore, we were able to detect and quantify 61 histone peptides from just 1,000 primary human stem cells. Detection of 37 histone peptides was possible from 1,000 acute myeloid leukemia patient cells. We anticipate that this revised method can be used in many applications where achieving large cell numbers is challenging, including rare human cell populations.
Evolution of regulatory signatures in primate cortical neurons at cell-type resolution
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Authors: Kozlenkov, Alexey; Vermunt, Marit W.; Apontes, Pasha; Li, Junhao; Hao, Ke; Sherwood, Chet C.; Hof, Patrick R.; Ely, John J.; Wegner, Michael; Mukamel, Eran A.; Creyghton, Menno P.; Koonin, Eugene V.; Dracheva, Stella
Abstract
The human cerebral cortex contains many cell types that likely underwent independent functional changes during evolution. How-ever, cell-type-specific regulatory landscapes in the cortex remain largely unexplored. Here we report epigenomic and transcriptomic analyses of the two main cortical neuronal subtypes, glutamatergic projection neurons and GABAergic interneurons, in human, chimpanzee, and rhesus macaque. Using genome-wide profiling of the H3K27ac histone modification, we identify neuron-subtype-specific regulatory elements that previously went undetected in bulk brain tissue samples. Human-specific regulatory changes are uncovered in multiple genes, including those associated with language, autism spectrum disorder, and drug addiction. We observe preferential evolutionary divergence in neuron subtype-specific regulatory elements and show that a substantial fraction of pan-neuronal regulatory elements undergoes subtype-specific evolutionary changes. This study sheds light on the interplay between regulatory evolution and celltype-dependent gene-expression programs, and provides a resource for further exploration of human brain evolution and function.